Avant Diagnostics Inc is a medical diagnostic technology company. Business activity of the group is functioned through United States. It focuses on the commercialization of a series of proprietary microarray-based diagnostic tests that provide early detection of cancers, neurodegenerative diseases, and other chronic and severe disease states. The company's premier product is OvaDx, a non-invasive proteomics diagnostic screening test for the early detection of ovarian cancer.
| Website: | www.avantdiagnostics.com |
| Main Phone: | +1 708 710-9200 |
| Address: | 1050 30th Street NW |
| Address 2: | Suite 107 |
| State: | DC |
| City / Town: | Washington |
| Country: | USA |
| Postal Code: | 20007 |
| Exchange: | NSD |
| CEO: | Michael Ruxin |
| Employees: | 1 |
| NAICS: | Electromedical and Electrotherapeutic Apparatus Manufacturing(334510) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume 0 | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 303,927,098.00 | EPS (TTM) N/A | PE Ratio N/A | Exchange NSD |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
